Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight
Neuro Oncol
.
2024 Apr 8:noae051.
doi: 10.1093/neuonc/noae051.
Online ahead of print.
Authors
Isabel Arrillaga-Romany
1
,
Julie J Miller
1
2
Affiliations
1
Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
2
Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
38588460
DOI:
10.1093/neuonc/noae051
No abstract available